Lexeo Therapeutics, Inc. Common Stock beat EPS estimates 100% of the time across 3 reported quarters (3 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.30 | $-0.30 | +0.0% | Beat |
| Q12026 FY2026 | $-0.29 | $-0.25 | +13.8% | Beat |
| Q42025 FY2025 | $-0.32 | $-0.27 | +15.6% | Beat |
Back to LXEO overview · LXEO holders · LXEO KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.